Abstract
The emerging field of proteomic molecular profiling will be driven by new technologies that can measure dozens to hundreds of proteins from a small sample input from a patient’s biopsy. Lysate arrays, or reverse-phase protein microarrays, provide a platform for complex mixtures of proteins extracted from cells and tissues to be directly immobilized onto a solid support (such as a biochip with protein binding capacity) in diminutive volumes (picoliter-to-nanoliter). The proteins are spotted using precision robotics and then quantitatively assayed using primary antibodies; important posttranslational modifications, such as phosphorylations that are important for protein activation, may also be assayed to provide an estimate of the regulation of cellular signaling. Until recently, chromogenic signals and fluorescence (using organic fluorophores) detection were two strategies relied upon for signal detection. Emerging regents such as quantum dots (Qdot® nanocrystals; QD) are now employed for improved performance. QD embody a more versatile detection system because the robust signals may be time averaged and the narrow spectral emissions enable many protein targets to be quantified within the same lysate spot. Previously, we found that commercially available pegylated, streptavidin-conjugated QD were effective detection agents, with low-background affinities to spurious components within heterogeneous protein mixtures. Hyperspectral imaging allows the simultaneous detection of the different colored QD reagents within a single lysate spot. Here, we described the construction and imaging of QD lysate arrays. This technology is an emerging, enabling tool within the exciting, clinically oriented field of clinical tissue proteomics.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Espina, V., Geho, D., Mehta, A. I., Petricoin, E. F., 3rd, Liotta, L. A., Rosenblatt, K. P. (2005) Pathology of the future: molecular profiling for targeted therapy. Cancer Invest 23, 36–46.
Liotta, L. A., Kohn, E. C. (2001) The microenvironment of the tumour-host interface. Nature 411, 375–9.
Liotta, L. A., Espina, V., Mehta, A. I., Calvert, V., Rosenblatt, K., Geho, D. et al. (2003) Protein microarrays: meeting analytical challenges for clinical applications. Cancer Cell 3, 317–25.
Paweletz, C. P., Charboneau, L., Bichsel, V. E., Simone, N. L., Chen, T., Gillespie, J. W. et al. (2001) Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene 20, 1981–9.
Haab, B. B. (2001) Advances in protein microarray technology for protein expression and interaction profiling. Curr Opin Drug Discov Devel 4, 116–23.
Bobrow, M. N., Harris, T. D., Shaughnessy, K. J., Litt, G. J. (1989) Catalyzed reporter deposition, a novel method of signal amplification. Application to immunoassays. J Immunol Methods 125, 279–85.
Bobrow, M. N., Litt, G. J., Shaughnessy, K. J., Mayer, P. C., Conlon, J. (1992) The use of catalyzed reporter deposition as a means of signal amplification in a variety of formats. J Immunol Methods 150, 145–9.
Sheehan, K. M., Calvert, V. S., Kay, E. W., Lu, Y., Fishman, D., Espina, V. et al. (2005) Use of reverse phase protein microarrays and reference standard development for molecular network analysis of metastatic ovarian carcinoma. Mol Cell Proteomics 4, 346–55.
Silvestri, A., Colombatti, A., Calvert, V. S., Deng, J., Mammano, E., Belluco, C. et al. (2010) Protein pathway biomarker analysis of human cancer reveals requirement for upfront cellular-enrichment processing. Lab Invest 90, 787–96.
Petricoin, E. F., 3rd, Espina, V., Araujo, R. P., Midura, B., Yeung, C., Wan, X. et al. (2007) Phosphoprotein pathway mapping: Akt/mammalian target of rapamycin activation is negatively associated with childhood rhabdomyosarcoma survival. Cancer Res 67, 3431–40.
Kornblau, S. M., Tibes, R., Qiu, Y., Chen, W., Kantarjian, H. M., Andreeff, M. et al. (2009) Functional proteomic profiling of AML predicts response and survival. Blood 113 (1);154–64.
Korf, U., Derdak, S., Tresch, A., Henjes, F., Schumacher, S., Schmidt, C. et al. (2008) Quantitative protein microarrays for time-resolved measurements of protein phosphorylation. Proteomics 8, 4603–12.
Geho, D., Lahar, N., Gurnani, P., Huebschman, M., Herrmann, P., Espina, V. et al. (2005) Pegylated, steptavidin-conjugated quantum dots are effective detection elements for reverse-phase protein microarrays. Bioconjug Chem 16, 559–66.
Michalet, X., Pinaud, F. F., Bentolila, L. A., Tsay, J. M., Doose, S., Li, J. J. et al. (2005) Quantum dots for live cells, in vivo imaging, and diagnostics. Science 307, 538–44.
Pinaud, F., Michalet, X., Bentolila, L. A., Tsay, J. M., Doose, S., Li, J. J. et al. (2006) Advances in fluorescence imaging with quantum dot bio-probes. Biomaterials 27, 1679–87.
Bruchez, M., Jr., Moronne, M., Gin, P., Weiss, S., Alivisatos, A. P. (1998) Semiconductor nanocrystals as fluorescent biological labels. Science 281, 2013–6.
Chan, W. C., Nie, S. (1998) Quantum dot bioconjugates for ultrasensitive nonisotopic detection. Science 281, 2016–8.
Huebschman, M. L., Schultz, R. A., Garner, H. R. (2002) Characteristics and capabilities of the hyperspectral imaging microscope. IEEE Eng Med Biol Mag 21, 104–17.
Huebschman, M. L., Rosenblatt, K. P., Garner, H. R. (2009) Hyperspectral microscopy imaging to analyze pathology samples with multi-colors reduces time and cost. Proc. SPIE 7182 7182F doi:10.1117/12.809277.
Katari, S., Wallack, M., Huebschman, M., Pantano, P., Garner, H. (2009) Fabrication and evaluation of a near-infrared hyperspectral imaging system. J Microsc 236, 11–7.
Schultz, R. A., Nielsen, T., Zavaleta, J. R., Ruch, R., Wyatt, R., Garner, H. R. (2001) Hyperspectral imaging: a novel approach for microscopic analysis. Cytometry 43, 239–47.
VanMeter, A. J., Rodriguez, A. S., Bowman, E. D., Jen, J., Harris, C. C., Deng, J. et al. (2008) Laser capture microdissection and protein microarray analysis of human non-small cell lung cancer: differential epidermal growth factor receptor (EGPR) phosphorylation events associated with mutated EGFR compared with wild type. Mol Cell Proteomics 7, 1902–24.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Rosenblatt, K.P., Huebschman, M.L., Garner, H.R. (2012). Construction and Hyperspectral Imaging of Quantum Dot Lysate Arrays. In: Espina, V., Liotta, L. (eds) Molecular Profiling. Methods in Molecular Biology, vol 823. Humana Press. https://doi.org/10.1007/978-1-60327-216-2_20
Download citation
DOI: https://doi.org/10.1007/978-1-60327-216-2_20
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60327-215-5
Online ISBN: 978-1-60327-216-2
eBook Packages: Springer Protocols